Effects of dietary vitamin E supplementation on pulmonary morphology and collagen deposition in amiodarone- and vehicle-treated hamsters

Amiodarone (AM) is a potent antidysrhythmic agent that is limited in clinical use by its adverse effects, including potentially life-threatening AM-induced pulmonary toxicity (AIPT). The present study tested the ability of dietary supplementation with vitamin E (500 IU d,l-α-tocopherol acetate/kg ch...

Full description

Saved in:
Bibliographic Details
Published inToxicology (Amsterdam) Vol. 133; no. 2; pp. 75 - 84
Main Authors Card, Jeffrey W., Leeder, Randall G., Racz, William J., Brien, James F., Bray, Tammy M., Massey, Thomas E.
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 15.04.1999
Amsterdam Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Amiodarone (AM) is a potent antidysrhythmic agent that is limited in clinical use by its adverse effects, including potentially life-threatening AM-induced pulmonary toxicity (AIPT). The present study tested the ability of dietary supplementation with vitamin E (500 IU d,l-α-tocopherol acetate/kg chow) to protect against pulmonary damage following intratracheal administration of AM (1.83 μmol) to the male golden Syrian hamster. At 21 days post-dosing, animals treated with AM had increased lung hydroxyproline content and histological disease index values compared to control ( P<0.05), which were indicative of fibrosis. Dietary vitamin E supplementation for 6 weeks resulted in a 234% increase in lung vitamin E content at the time of AM dosing, and maintenance on the diet prevented AM-induced elevation of hydroxyproline content and disease index 21 days post-dosing. Dietary vitamin E supplementation also decreased hydroxyproline content and disease index values in hamsters treated intratracheally with distilled water, the AM vehicle. These results demonstrate a protective role for vitamin E in an in vivo model of AIPT, and suggest that this antioxidant may have non-specific antifibrotic effects in the lung.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0300-483X
1879-3185
DOI:10.1016/S0300-483X(99)00009-8